Clinical and genetic risk factors for Fulvestrant treatment in post-menopause ER-positive advanced breast cancer patients.

J Transl Med · 2019 · PMC6334389 · PMID 30646914

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginal significanceno p-value reported

All tests of hypotheses were two-tailed and conducted at a significance level of 0.05, and at a marginal significance level of 0.15.

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.